Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Cash Flow Reinvestment Rate
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd cash flow reinvestment rate. Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Cash Flow Reinvestment Rate of 0.20x as of June 2025, reinvesting CN¥7.27 Million (capex CN¥7.27 Million ) from operating cash flow of CN¥36.25 Million. Explore Tonghua Golden-Horse Pharmaceutical Indu cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2025)
Cash flow reinvestment rate of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2000 to 2025. Historical reinvestment intensity for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd across 21 annual periods. Explore 000766 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Cash Flow Reinvestment Rate by Year (2000–2025)
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd cash flow reinvestment rate by year from 2000 to 2025. Year-by-year capital reinvestment analysis for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd. For the full cash flow conversion analysis, see 000766 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | CN¥64.07 Million | CN¥105.05 Million | CN¥64.07 Million | ▲ +1.0% |
| 2024 | 0.60x | CN¥98.30 Million | CN¥162.75 Million | CN¥49.17 Million | ▼ -31.7% |
| 2023 | 0.88x | CN¥99.80 Million | CN¥112.78 Million | CN¥26.67 Million | ▲ +611.4% |
| 2022 | 0.12x | CN¥24.65 Million | CN¥198.16 Million | CN¥23.74 Million | ▼ -32.5% |
| 2021 | 0.18x | CN¥25.49 Million | CN¥138.33 Million | CN¥25.48 Million | ▼ -97.1% |
| 2020 | 6.40x | CN¥516.17 Million | CN¥80.71 Million | CN¥19.16 Million | ▼ -47.3% |
| 2019 | 12.14x | CN¥908.82 Million | CN¥74.86 Million | CN¥60.98 Million | ▲ +772.1% |
| 2018 | 1.39x | CN¥237.66 Million | CN¥170.72 Million | CN¥74.40 Million | ▼ -81.1% |
| 2017 | 7.37x | CN¥194.94 Million | CN¥26.43 Million | CN¥118.10 Million | ▼ -58.5% |
| 2016 | 17.77x | CN¥1.61 Billion | CN¥90.63 Million | CN¥169.40 Million | ▲ +232.5% |
| 2014 | 5.34x | CN¥183.39 Million | CN¥34.32 Million | CN¥183.39 Million | ▲ +249.0% |
| 2013 | 1.53x | CN¥157.66 Million | CN¥102.96 Million | CN¥157.66 Million | ▲ +336.0% |
| 2010 | 0.35x | CN¥10.20 Million | CN¥29.05 Million | CN¥10.20 Million | ▲ +113.7% |
| 2009 | 0.16x | CN¥13.14 Million | CN¥79.94 Million | CN¥13.14 Million | ▼ -77.5% |
| 2008 | 0.73x | CN¥7.48 Million | CN¥10.26 Million | CN¥7.48 Million | ▲ +41.6% |
| 2007 | 0.51x | CN¥5.12 Million | CN¥9.95 Million | CN¥5.12 Million | ▲ +4.8% |
| 2005 | 0.49x | CN¥17.55 Million | CN¥35.74 Million | CN¥17.55 Million | ▲ +115.1% |
| 2004 | 0.23x | CN¥4.37 Million | CN¥19.12 Million | CN¥4.37 Million | ▼ -74.6% |
| 2003 | 0.90x | CN¥82.57 Million | CN¥91.99 Million | CN¥82.57 Million | ▲ +277.1% |
| 2002 | 0.24x | CN¥17.31 Million | CN¥72.70 Million | CN¥17.31 Million | ▼ -87.0% |
| 2000 | 1.84x | CN¥360.49 Million | CN¥196.15 Million | CN¥360.49 Million | — |